Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited has successfully secured a A$70 million capital raise, bolstered by a strategic A$7.5 million investment from Lantheus Holdings. The overwhelming support at the EGM underscores the market’s confidence in Radiopharm’s innovative oncology radiopharmaceuticals and its potential for growth and market expansion. This financial milestone is set to propel Radiopharm’s clinical developments and strengthen its global presence in the high-demand medical sector.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.